NUTRA PHARMA CORP. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements)
NUTRA PHARMA CORP. (NPHC) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements) of $948.05 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-04-17.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements · last filed 2018-04-17
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, purchases, (sales), issuances, (settlements) for the quarter ending 2016-12-31 was $301.93K, a 74.27% decline year-over-year.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, purchases, (sales), issuances, (settlements) for the quarter ending 2016-09-30 was $260.45K.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, purchases, (sales), issuances, (settlements) for the quarter ending 2016-06-30 was $514.55K, a 138.50% increase year-over-year.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, purchases, (sales), issuances, (settlements) for the quarter ending 2016-03-31 was -$128.88K.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, purchases, (sales), issuances, (settlements) for fiscal 2016 was $948.05K, a 6.33% decline from fiscal 2015.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, purchases, (sales), issuances, (settlements) for fiscal 2015 was $1.01M.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, purchases, (sales), issuances, (settlements) for fiscal 2014 was -$155.17K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements) 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements) 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | $301.93K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | $562.38K derived: sum of 2 quarters · filed 2018-04-17 | $1.08M derived: sum of 3 quarters · filed 2018-04-17 | $948.05K 10-K · filed 2018-04-17 | |
| 2016-09-30 | $260.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-22 | $775.00K derived: sum of 2 quarters · filed 2016-11-22 | $646.12K 10-Q · filed 2016-11-22 | $1.82M derived: sum of 4 quarters · filed 2017-04-17 | |
| 2016-06-30 | $514.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-22 | $385.67K 10-Q · filed 2016-08-22 | $1.56M derived: sum of 3 quarters · filed 2017-04-17 | $1.34M derived: sum of 4 quarters · filed 2017-04-17 | |
| 2016-03-31 | -$128.88K 10-Q · filed 2016-06-21 | $1.04M derived: sum of 2 quarters · filed 2017-04-17 | $822.70K derived: sum of 3 quarters · filed 2017-04-17 | $1.04M derived: sum of 4 quarters · filed 2017-04-17 | |
| 2015-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | $951.58K derived: sum of 2 quarters · filed 2017-04-17 | $1.17M derived: sum of 3 quarters · filed 2017-04-17 | $1.01M 10-K · filed 2017-04-17 | $738.25K 10-K · filed 2016-04-14 |
| 2015-09-30 | -$221.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-23 | -$6.08K derived: sum of 2 quarters · filed 2015-11-23 | -$161.26K 10-Q · filed 2015-11-23 | ||
| 2015-06-30 | $215.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-18 | $60.57K 10-Q · filed 2015-08-18 | |||
| 2015-03-31 | -$155.17K 10-Q · filed 2016-06-21 | ||||
| 2014-12-31 | -$155.17K 10-K · filed 2016-04-14 |